{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:25:39Z","timestamp":1791685539751,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T00:00:00Z","timestamp":1617580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"MSMT CR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"GA\u010cR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejmech.2021.113434","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T13:50:36Z","timestamp":1618926636000},"page":"113434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors"],"prefix":"10.1016","volume":"219","author":[{"given":"Lukas","family":"Gorecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Misiachna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Damborsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Dolezal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lada","family":"Cejkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Hakenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7630-7362","authenticated-orcid":false,"given":"Marketa","family":"Chvojkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana Zdarova","family":"Karasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-4478","authenticated-orcid":false,"given":"Lukas","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1722-169X","authenticated-orcid":false,"given":"Marharyta","family":"Kolcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stepan","family":"Kortus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Vales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-051X","authenticated-orcid":false,"given":"Martin","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113434_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From magic bullets to designed multiple ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2021.113434_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by design: a medicinal chemist\u2019s perspective on multitargeting compounds","volume":"62","author":"Proschak","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib3","article-title":"From combinations to multitarget-directed ligands: a continuum in Alzheimer\u2019s disease polypharmacology","author":"Albertini","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113434_bib4","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A\u00a0perspective on multi-target drugs for alzheimer\u2019s disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113434_bib6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/14656566.2018.1519022","article-title":"An evaluation of memantine ER+ donepezil for the treatment of Alzheimer\u2019s disease","volume":"19","author":"Calhoun","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113434_bib7","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1021\/jm3009458","article-title":"Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer\u2019s disease","volume":"55","author":"Simoni","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep33172","article-title":"In\u00a0vivo characterization of ARN14140, a memantine\/galantamine-based multi-target compound for Alzheimer\u2019s disease","volume":"6","author":"Reggiani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113434_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbadis.2016.11.020","article-title":"Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer\u2019s disease treatment","volume":"1863","author":"Gazova","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2021.113434_bib10","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3390\/molecules18022397","article-title":"7-Methoxytacrine-Adamantylamine heterodimers as cholinesterase inhibitors in alzheimer\u2019s disease treatment \u2014 synthesis, biological evaluation and molecular modeling studies","author":"Spilovska","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113434_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2174\/1567205016666190228122218","article-title":"Combination of memantine and 6-chlorotacrine as novel multi-target compound against Alzheimer\u2019s disease","volume":"16","author":"Kaniakova","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2021.113434_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0306-4522(01)00206-8","article-title":"Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons","volume":"105","author":"Zhang","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2021.113434_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2008.02.133","article-title":"Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors","volume":"369","author":"Liu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113434_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2017.01.003","article-title":"The pharmacology of tacrine at N-methyl-d-aspartate receptors","volume":"75","author":"Horak","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2021.113434_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuropharm.2018.08.010","article-title":"7-Methoxyderivative of tacrine is a \u2018foot-in-the-door\u2019open-channel blocker of GluN1\/GluN2 and GluN1\/GluN3 NMDA receptors with neuroprotective activity in\u00a0vivo","volume":"140","author":"Kaniakova","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2021.113434_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainresbull.2012.10.005","article-title":"Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects","volume":"93","author":"Vizi","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2021.113434_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41467-019-08291-1","article-title":"Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors","volume":"10","author":"Regan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113434_bib18","first-page":"183","article-title":"NMDA receptor subtypes: structure, function and therapeutics","volume":"19","author":"Chaffey","year":"2008","journal-title":"Curr. Anaesth. Crit. Care"},{"key":"10.1016\/j.ejmech.2021.113434_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113434_bib20","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood\u2013brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejmech.2019.07.051","article-title":"A\u00a0novel class of multitarget anti-Alzheimer benzohomoadamantane\u2012chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors","volume":"180","author":"P\u00e9rez-Areales","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib22","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.3390\/molecules19079307","article-title":"N-alkyl carbazole derivatives as new tools for Alzheimer\u2019s disease: preliminary studies","volume":"19","author":"Saturnino","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113434_bib23","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/molecules25174005","article-title":"Memantine derivatives as multitarget agents in alzheimer\u2019s disease","volume":"25","author":"Marotta","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113434_bib24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/138920008784220619","article-title":"Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer\u2019s disease","volume":"9","author":"Patocka","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2021.113434_bib25","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1021\/jm990971t","article-title":"SAR of 9-amino-1, 2, 3, 4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues","volume":"43","author":"Recanatini","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejmech.2009.10.039","article-title":"Synthesis and AChE inhibitory activity of new chiral tetrahydroacridine analogues from terpenic cyclanones","volume":"45","author":"dos Santos Pisoni","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-014-0084-0","article-title":"QSAR analysis on tacrine-related acetylcholinesterase inhibitors","volume":"21","author":"Wong","year":"2014","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ejmech.2021.113434_bib28","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bmcl.2006.11.022","article-title":"Quantitative structure\u2013activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections","volume":"17","author":"Jung","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113434_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4155\/fmc-2017-0019","article-title":"New (benz) imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease","volume":"9","author":"Boulebd","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib30","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.4155\/fmc-2019-0027","article-title":"Tacroximes: novel unique compounds for the recovery of organophosphorus-inhibited acetylcholinesterase","volume":"11","author":"Gorecki","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113434_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer\u2019s disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.ejmech.2021.113434_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113434_bib34","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1016\/j.bmcl.2010.08.044","article-title":"Synthesis and in\u00a0vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease","volume":"20","author":"Korabecny","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113434_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2021.113434_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biom11010003","article-title":"Pursuing the complexity of alzheimer\u2019s disease: discovery of fluoren-9-amines as selective butyrylcholinesterase inhibitors and N-Methyl-d-Aspartate receptor antagonists","volume":"11","author":"Konecny","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2021.113434_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","article-title":"Mordred: a molecular descriptor calculator","volume":"10","author":"Moriwaki","year":"2018","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2021.113434_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113434_bib39","series-title":"In\u00a0Vitro and in Silico Evaluation of Non-quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning-A New Hope or a Blind Alley?, Medicinal Chemistry","author":"Soukup","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113434_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tiv.2004.06.011","article-title":"In\u00a0vitro models for the blood\u2013brain barrier","volume":"19","author":"Garberg","year":"2005","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2021.113434_bib41","first-page":"1","article-title":"Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats","author":"Zdarova Karasova","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113434_bib42","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0090-9556(25)07381-7","article-title":"Distribution of tacrine and metabolites in rat brain and plasma after single-and multiple-dose regimens. Evidence for accumulation of tacrine in brain tissue","volume":"24","author":"McNally","year":"1996","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejmech.2021.113434_bib43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.STR.26.4.602","article-title":"Safety and tolerability of the glutamate antagonist CGS 19755 (selfotel) in patients with acute ischemic stroke: results of a phase IIa randomized trial","volume":"26","author":"Grotta","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2021.113434_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejmech.2021.113434_bib45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.STR.26.3.503","article-title":"Clinical experience with excitatory amino acid antagonist drugs","volume":"26","author":"Muir","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2021.113434_bib46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0091-3057(00)00409-3","article-title":"Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats","volume":"67","author":"Bast","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2021.113434_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbr.2010.08.001","article-title":"Effect of \u2018chronic\u2019versus \u2018acute\u2019ketamine administration and its \u2018withdrawal\u2019effect on behavioural alterations in mice: implications for experimental psychosis","volume":"216","author":"Chatterjee","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2021.113434_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hipo.20367","article-title":"A\u00a0single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats","volume":"18","author":"Manahan-Vaughan","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.ejmech.2021.113434_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0091-3057(97)98986-3","article-title":"Motor dysfunction produced by tacrine administration in rats","volume":"58","author":"Carriero","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2021.113434_bib50","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/sj.npp.1300761","article-title":"Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice","volume":"30","author":"Csernansky","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2021.113434_bib51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000211668","article-title":"Comparison studies of tacrine and bis (7)-tacrine on the suppression of scopolamine-induced behavioral changes and inhibition of acetylcholinesterase in mice","volume":"83","author":"Pan","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejmech.2021.113434_bib52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00001756-199903170-00023","article-title":"Effects of bis (7)-tacrine, a novel anti-Alzheimer\u2019s agent, on rat brain AChE","volume":"10","author":"Wang","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejmech.2021.113434_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2003.11.080","article-title":"Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer\u2019s disease","volume":"486","author":"Liston","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113434_bib54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","article-title":"Novel tacrine-tryptophan hybrids: multi-target directed ligands as potential treatment for Alzheimer\u2019s disease","volume":"168","author":"Chalupova","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113434_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-75646-w","article-title":"The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors","volume":"10","author":"Skrenkova","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113434_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/jnc.12002","article-title":"Single amino acid residue in the M4 domain of GluN1 subunit regulates the surface delivery of NMDA receptors","volume":"123","author":"Kaniakova","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2021.113434_bib57","doi-asserted-by":"crossref","first-page":"114460","DOI":"10.1016\/j.bcp.2021.114460","article-title":"7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in\u00a0vivo","author":"Kaniakova","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113434_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cem.1180020306","article-title":"PLS regression methods","volume":"2","author":"H\u00f6skuldsson","year":"1988","journal-title":"J.\u00a0Chemom."},{"key":"10.1016\/j.ejmech.2021.113434_bib59","series-title":"PLS: Partial Least Squares Projections to Latent Structures","author":"Wold","year":"1993"},{"key":"10.1016\/j.ejmech.2021.113434_bib60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/ci00037a002","article-title":"Multivariate quantitative structure-activity relationships (QSAR): conditions for their applicability","volume":"23","author":"Wold","year":"1983","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2021.113434_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/qsar.19910100302","article-title":"Validation of QSAR\u2019s","volume":"10","author":"Wold","year":"1991","journal-title":"Quant. Struct.-Act. Relat."},{"key":"10.1016\/j.ejmech.2021.113434_bib62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.toxlet.2019.11.021","article-title":"Encapsulation of oxime K027 into cucurbit [7] uril: in\u00a0vivo evaluation of safety, absorption, brain distribution and reactivation effectiveness","volume":"320","author":"Karasova","year":"2020","journal-title":"Toxicol. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342100283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342100283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:29:41Z","timestamp":1759328981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342100283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":62,"alternative-id":["S022352342100283X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113434","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113434"}}